MTX1

MTX1 (Metaxin 1) is a mitochondrial protein that influences autophagy and, through it, cell survival under stress (PMID:8660965, PMID:34421355). It is a 317-residue protein that lacks an amino-terminal signal sequence but carries a putative transmembrane domain near its carboxy terminus, consistent with a tail-anchored topology in the mitochondrial outer membrane (PMID:8660965). Functionally, MTX1 physically interacts with and inhibits CISD1, a negative regulator of autophagy; this interaction relieves CISD1's restraint on autophagic flux, and MTX1 overexpression thereby augments autophagy to promote sorafenib resistance, increased proliferation, and reduced apoptosis in hepatocellular carcinoma cells and xenografts (PMID:34421355). The MTX1 gene resides at the GBA locus, and a coding variant (p.S63T) on the allele trans to GBA mutations is associated with earlier age of motor symptom onset in GBA-associated Parkinson's disease (PMID:8660965, PMID:21837367). Beyond these findings, the biochemical basis of MTX1's transmembrane insertion and the structural detail of the MTX1-CISD1 interface have not been characterized in the available corpus.

1. 1996 Medium

   Established the molecular identity of human MTX1 as a mitochondrial protein with a defined topology and genomic context, framing it as a tail-anchored outer-membrane candidate rather than a secreted or matrix protein.

   Evidence cDNA sequencing, genomic cloning, exon-intron mapping, and Northern blot in human tissues

   PMID:8660965

   Open questions at the time

   • Transmembrane domain and lack of signal sequence inferred from sequence prediction, not experimentally validated
   • Submitochondrial localization and membrane orientation not directly demonstrated
   • No functional role assigned
2. 2011 Low

   Connected MTX1 sequence variation to clinical phenotype, showing the p.S63T variant on the trans allele modifies age of onset in GBA-associated Parkinson's disease.

   Evidence Genotyping of MTX1 coding region in 600 Ashkenazi PD patients and 353 controls with age-of-onset association analysis

   PMID:21837367

   Open questions at the time

   • Genetic association without functional mechanistic follow-up
   • No direct experiment on MTX1 protein function
   • Single cohort; linkage with GBA confounds attribution to MTX1
3. 2021 Medium

   Defined a direct molecular mechanism for MTX1 in autophagy regulation, showing it inhibits CISD1 to drive autophagy-mediated drug resistance in cancer.

   Evidence CRISPRa genome-scale screen, MTX1-CISD1 co-immunoprecipitation, gain/loss-of-function assays, and subcutaneous xenograft model in hepatocellular carcinoma

   PMID:34421355

   Open questions at the time

   • Interaction shown by Co-IP without structural definition of the binding interface
   • Mechanism by which CISD1 inhibition increases autophagy flux not resolved at the molecular level
   • Demonstrated in HCC context; generality across tissues unknown

• How MTX1's outer-membrane topology relates to its CISD1-dependent autophagy function, and whether the Parkinson's-associated variant alters this activity, remains unresolved.
• No structural model of the MTX1-CISD1 complex
• No link established between the p.S63T variant and any biochemical or autophagy phenotype
• Membrane insertion mechanism not experimentally characterized